The Intracept ® is an intraosseous nerve ablation procedure used in conjunction with radiofrequency (RF) generators for the ablation of basivertebral nerves for the relief of chronic low back pain that has not responded to at least six months of conservative care.
The Intracept ®Procedure is a minimally invasive procedure that targets the basivertebral nerve for the relief of chronic vertebrogenic low back pain.
Under fluoroscopic guidance, the Intracept Introducer Cannula is advanced through the pedicle.
The Intracept Curved Cannula is utilized to create a channel to the trunk of the basivertebral nerve.
The Intracept Radiofrequency Probe is inserted into the curved path and placed at the basivertebral nerve.
The Relievant Radiofrequency Generator is utilized to ablate the basivertebral nerve.
Modic Type 1:
Hypointense T1W and Hyperintense T2W MR
Modic Type 2:
Hyperintense T1W and T2W MR
Chronic Vertebrogenic Low Back Pain
The Intracept Intraosseous Nerve Ablation System is used in conjunction with radiofrequency (RF) generators for the ablation of basivertebral nerves of the L3 through S1 vertebrae for the relief of chronic low back pain. The Intracept relieves chronic low back pain that is present for a period of at least six months, has not improved with at least six months of conservative care and a MRI that displays features consistent with Type 1 or Type 2 Modic changes and/or inflammation, edema, vertebral end plate changes, disruption and fissuring of the endplate, vascularized fibrous tissues within the adjacent marrow, hypointensive signals (Type 1 Modic change), and changes to the vertebral body marrow including, replacement of normal bone marrow by fat, and hyperintensive signals (Type 2 Modic change).
Use of the Intracept Intraosseous Nerve Ablation System is contraindicated in:
The Interventional Pain Physicians at Centennial Spine & Pain are committed to utilizing safe and effective treatments that are carefully designed to reduce the risk and maximize the benefits in each situation. Our committed and caring physicians employ an individualized, patient-centered approach to managing, treating, and eliminating pain through comprehensive treatment methods.
David Lanzkowsky, MD
The Intracept Procedure is supported by two Level l randomized clinical trials. Intracept has demonstrated statistical significance compared to both standard care and sham, consistent improvement in both pain and function across both trials, and durable results beyond five years post-procedure. For more information click here.
Relievant is committed to providing patients, physicians and facilities with resources to assist in the reimbursement process and to gain patient access for treatment with the Intracept Procedure. Relievant has a dedicated team of professionals to assist in the prior authorization of the Intracept Procedure. The prior authorization process involves obtaining advance notification from an insurance company that medical necessity and other coverage criteria have been met as set forth by the insurance company. The Relievant team works alongside the patient and physician throughout the prior authorization process in an attempt to obtain approval for the Intracept Procedure. For more information, click here.
We are committed to empowering our patients to achieve their goals.
Call today at 702-839-1203.
